The United States Food and Drug Administration conducted inspection at Unichem Laboratories’ Active Pharmaceutical Ingredients manufacturing unit located at Roha between February 17 and 21. The inspection was a routine cGMP surveillance and successfully concluded without any FDA form 483 issued, it said in notices to stock exchanges. Shares of Unichem Laboratories closed 8.5 per cent higher at ₹148.25 on the BSE.
Company news: USFDA conducts inspection at Unichem Lab's manufacturing unit
Published on
February 25, 2020 03:13